{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:14:47Z","timestamp":1788012887423,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.04.023","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T03:13:12Z","timestamp":1619579592000},"page":"3018-3024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap"],"prefix":"10.1016","volume":"39","author":[{"given":"Akihiko","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.04.023_b0005","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1016\/j.vaccine.2014.06.022","article-title":"Recent progress and concerns regarding the Japanese immunization program: addressing the \u201cvaccine gap\u201d","volume":"32","author":"Saitoh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0010","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/j.vaccine.2018.01.092","article-title":"N. Progress and Challenges for the Japanese Immunization Program: Beyond the \u201cVaccine Gap\u201d","volume":"36","author":"Saitoh","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0015","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.vaccine.2012.04.026","article-title":"Current issues with the immunization program in Japan: can we fill the \u201cvaccine gap\u201d?","volume":"30","author":"Saitoh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1473-3099(12)70029-4","article-title":"Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?","volume":"12","author":"Patel","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ped.14150","article-title":"Rotavirus genotype and Vesikari score of outpatients in Japan in the vaccine era","volume":"62","author":"Ono","year":"2020","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2021.04.023_b0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12199-017-0638-3","article-title":"Changes in the numbers of patients with acute gastroenteritis after voluntary introduction of the rotavirus vaccine in a Japanese children's primary emergency medical center","volume":"22","author":"Morioka","year":"2017","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.vaccine.2021.04.023_b0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7883\/yoken.67.304","article-title":"The occurrence of severe rotavirus gastroenteritis in children under 3 years of age before and after the introduction of rotavirus vaccine: a prospective observational study in three pediatric clinics in Shibata City, Niigata Prefecture, Japan","volume":"67","author":"Oishi","year":"2014","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0040","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2018.07.007","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children","volume":"36","author":"Araki","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0045","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.vaccine.2017.10.033","article-title":"Decline of rotavirus-coded hospitalizations in children under 5 years: A report from Japan where rotavirus vaccines are self-financed","volume":"36","author":"Kobayashi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12887-017-0916-7","article-title":"Effectiveness of rotavirus vaccines against hospitalisations in Japan","volume":"17","author":"Fujii","year":"2017","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2021.04.023_b0055","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7883\/yoken.64.482","article-title":"Rotavirus-associated acute gastroenteritis hospitalizations among Japanese children aged <5 years: active rotavirus surveillance in Mie Prefecture, Japan","volume":"64","author":"Kamiya","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jiac.2019.09.001","article-title":"The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine","volume":"26","author":"Kawase","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2021.04.023_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7883\/yoken.65.301","article-title":"Incidence of intussusception as studied from a hospital-based retrospective survey over a 10-year period (2001\u20132010) in Akita Prefecture, Japan","volume":"65","author":"Noguchi","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5365\/wpsar.2016.7.3.005","article-title":"Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan","volume":"7","author":"Asada","year":"2016","journal-title":"Western Pacific Surveil Respon J : WPSAR."},{"key":"10.1016\/j.vaccine.2021.04.023_b0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7883\/yoken.JJID.2019.198","article-title":"Rotavirus Vaccine Effectiveness against the Risk of Hospitalization and the Impact of Using Public Funds for the Vaccine on a Regional Rotavirus Gastroenteritis Epidemic in Japan","volume":"73","author":"Sato","year":"2020","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0080","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.vaccine.2017.03.015","article-title":"Expert Council on Promotion of V. Consensus statement from 17 relevant Japanese academic societies on the promotion of the human papillomavirus vaccine","volume":"35","author":"Iwata","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0085","unstructured":"Rotavirus vaccines. WHO position paper - January 2013. Releve epidemiologique hebdomadaire \/ Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations. 2013;88:49\u201364."},{"key":"10.1016\/j.vaccine.2021.04.023_b0090","unstructured":"Ministry of Labor W, and Health. Mistakes related to immunization (Fiscal year of 2017, in Japanese); 2019. https:\/\/wwwmhlwgojp\/content\/10601000\/000553930pdf."},{"key":"10.1016\/j.vaccine.2021.04.023_b0095","unstructured":"Japan Pediatric Society. Vaccine Information Statement by Japan Pediatric Society (in Japanese); 2018. http:\/\/www.jpeds.or.jp\/modules\/activity\/index.php?content_id=263"},{"key":"10.1016\/j.vaccine.2021.04.023_b0100","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/j.vaccine.2020.10.049","article-title":"Effect of a vaccine information statement (VIS) on immunization status and parental knowledge, attitudes, and beliefs regarding infant immunization in Japan","volume":"38","author":"Saitoh","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0105","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.vaccine.2018.01.048","article-title":"School-age children and adolescents suspected of having been to be infected with pertussis in Japan","volume":"36","author":"Yasui","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0110","unstructured":"Diseases NIoI. Epidemiology of pertussis cases in Japan by national surveillance (in Japanese); 2020. https:\/\/wwwniidgojp\/niid\/ja\/pertussis-m\/pertussis-idwrs\/9463-pertussis-20200306html."},{"key":"10.1016\/j.vaccine.2021.04.023_b0115","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","article-title":"HPV vaccination crisis in Japan","volume":"385","author":"Hanley","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.04.023_b0120","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV Vaccination and the Risk of Invasive Cervical Cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.04.023_b0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/infdis\/jiy516","article-title":"Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection","volume":"219","author":"Kudo","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12879-020-05513-6","article-title":"Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women","volume":"20","author":"Shiko","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.023_b0135","first-page":"1","article-title":"Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study","author":"Tozawa-Ono","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.04.023_b0140","article-title":"Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study","author":"Ikeda","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.vaccine.2021.04.023_b0145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jiac.2019.02.012","article-title":"Effectiveness on high-grade cervical abnormalities and long-term safety of the quadrivalent human papillomavirus vaccine in Japanese women","volume":"25","author":"Sakamoto","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2021.04.023_b0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pvr.2018.02.002","article-title":"No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study","volume":"5","author":"Suzuki","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vaccine.2021.04.023_b0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jog.14227","article-title":"Human papillomavirus vaccination and postural tachycardia syndrome, deconditioning and exercise-induced hyperalgesia: An alternate interpretation of the reported adverse reactions","volume":"46","author":"Ishizaki","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.vaccine.2021.04.023_b0160","doi-asserted-by":"crossref","first-page":"16091","DOI":"10.1038\/s41598-020-73120-1","article-title":"The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation","volume":"10","author":"Ueda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.04.023_b0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(95)92311-X","article-title":"Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan","volume":"346","author":"Ueda","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.04.023_b0170","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.vaccine.2015.09.068","article-title":"Effect of age on the incidence of aseptic meningitis following immunization with monovalent mumps vaccine","volume":"33","author":"Muta","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0175","unstructured":"Organization WH. Seasonal Influenza. https:\/\/wwwwhoint\/ith\/vaccines\/seasonal_influenza\/en\/."},{"key":"10.1016\/j.vaccine.2021.04.023_b0180","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2019.05.090","article-title":"Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013\u201318","volume":"37","author":"Shinjoh","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0185","doi-asserted-by":"crossref","first-page":"630","DOI":"10.15585\/mmwr.mm6920e1","article-title":"Decline in Child Vaccination Coverage During the COVID-19 Pandemic - Michigan Care Improvement Registry, May 2016-May 2020","volume":"69","author":"Bramer","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.04.023_b0190","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.19.2000848","article-title":"Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020","volume":"25","author":"McDonald","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2021.04.023_b0195","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1016\/j.vaccine.2020.08.019","article-title":"Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data","volume":"38","author":"Chandir","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.023_b0200","unstructured":"Japan Pediatric Society CoIaID. Childhood immunization uder the epidemic of COVID-19 (in Japanese); 2020. http:\/\/wwwjpedsorjp\/modules\/activity\/indexphp?content_id=345."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:56:12Z","timestamp":1759402572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X21004606"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}